Apple (AAPL) Added to BofA US 1 List, Jazz Pharmaceuticals (JAZZ) Removed
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/23/2026
Go back to Apple (AAPL) Added to BofA US 1 List, Jazz Pharmaceuticals (JAZZ) Removed
January 25, 2024 4:42 PM EST
JPMorgan analyst William Yang reiterated an Overweight rating on Apple (NASDAQ: AAPL).
The analyst comments "Apple will enable alternative app stores for consumers to download apps, and the ability to use alternative payment systems starting March of this year. Apple is charging a lower commission rate in the range of 10% to 17% (vs. prior rates of 15% to 30%) for apps sold through the... More
January 25, 2024 4:43 AM EST
Goldman Sachs analyst Michael Ng reiterated a Conviction Buy rating and $223.00 price target on Apple (NASDAQ: AAPL).
The analyst comments "We expect AAPL to deliver relatively in-line results for F1Q24 with EPS of $2.10 (v. FactSet consensus of $2.10) and revenue of $117.4 bn (v. consensus of $118.1 bn). Services revenue should grow 11% yoy (including a ~7pp... More
